MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

Core Viewpoint - MannKind Corporation is set to release its third quarter 2025 financial results on November 5, 2025, before market opening [1] Group 1: Financial Results Announcement - The financial results will be discussed in a webcast starting at 9 a.m. Eastern Time on the same day [2] - The webcast will be available on MannKind's investor relations website, with a replay accessible for approximately 90 days [2] Group 2: Company Overview - MannKind Corporation is a biopharmaceutical company focused on innovative solutions for chronic disease care, particularly in cardiometabolic and orphan lung diseases [3] - The company develops treatments for serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease [3] - MannKind specializes in drug-device combinations to create therapies that integrate seamlessly into patients' daily lives [4]